Q2 2025 Clarivate PLC Earnings Call Transcript
Key Points
- Clarivate PLC (CLVT) reported solid second-quarter financial performance with growth in key metrics, including a 1.3% increase in organic ACV and a 500 basis point rise in adjusted EBITDA margin.
- The company successfully launched 10 cutting-edge products and AI-powered capabilities, enhancing its subscription-based solutions.
- Clarivate PLC (CLVT) achieved a 96% renewal rate in its A&G segment, with 75% of global A&G subscriptions for the full year already renewed.
- The IP segment returned to growth, driven by a surge in AI-related patent filings, positioning the company to benefit from AI innovation trends.
- The Life Sciences and Healthcare segment saw a return to organic ACV growth, supported by strategic partnerships and product innovations like Cortellis and DRG Commercial Analytics 360.
- Clarivate PLC (CLVT) experienced a net loss of $72 million in the second quarter, attributed to non-cash impairment charges from the previous year.
- The company faced challenges with disposals and divestitures, impacting revenue by $64 million and adjusted EBITDA by $30 million in the first half of the year.
- The Life Sciences & Healthcare segment's commercialization market remains relatively soft, affecting overall performance.
- Clarivate PLC (CLVT) is dealing with potential impacts from changes in the US patent fee structure, which could affect its IP business.
- The disposal process for certain non-core assets is taking longer than expected, partly due to customer requests for extended timelines.
Thank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Clarivate second-quarter 2025 earnings conference call.
(Operator Instructions)
I would now like to turn the call over to Mark Donohue, Vice President of Investor Relations. Please go ahead.
Thank you, Jordan, and good morning everyone.
Thank you for joining us for the Clarivate second quarter of 2025 earnings conference call.
As a reminder, this call is being recorded, webcast and is copyrighted property of Clarivate. Any rebroadcast of this information in whole or in part without prior consent of Clarivate is prohibited, and accompanying earnings call presentation is available in the Investor Relations section of the company's website.
During our call, we may make certain forward-looking statements within the meaning of the applicable securities laws. Such forward-looking statements involve known and unknown risks,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
